ADALIPCA 40MG

Manufacturer
IPCA LABORTARIES LTD
Packaging
Vial
Composition
ADALIMUMAB INJECTION
Availability
OTC
SKU
PROD-00731

Product Description

🔹 Product Overview
Adalipca 40 mg Injection is a prescription biologic medicine used for the treatment of various autoimmune and inflammatory conditions. It contains Adalimumab 40 mg, a Tumor Necrosis Factor (TNF) inhibitor that helps reduce inflammation and control immune system activity.
Adalipca 40 mg is commonly prescribed for conditions such as rheumatoid arthritis, ankylosing spondylitis, psoriasis, psoriatic arthritis, Crohn’s disease, and ulcerative colitis under specialist medical supervision.

🔹 Key Uses
Treatment of rheumatoid arthritis
Management of ankylosing spondylitis
Treatment of psoriatic arthritis
Helps control moderate to severe plaque psoriasis
Used in Crohn’s disease and ulcerative colitis management
Helps reduce joint pain, swelling, stiffness, and inflammation associated with autoimmune disorders

🔹 Composition
Active Ingredient: Adalimumab 40 mg
Dosage Form: Subcutaneous injection
Drug Class: TNF-alpha inhibitor / Biologic DMARD
Therapeutic Category: Immunosuppressive and anti-inflammatory biologic therapy

🔹 How It Works
Adalipca 40 mg Injection works by blocking Tumor Necrosis Factor-alpha (TNF-α), a natural substance in the body that plays a major role in inflammation. By reducing TNF activity, it helps decrease excessive immune responses, inflammation, joint damage, and symptoms related to autoimmune diseases.

🔹 Key Benefits
Helps reduce inflammation and autoimmune disease symptoms
Improves joint movement and reduces stiffness
Helps control skin inflammation in psoriasis
Supports long-term management of chronic inflammatory conditions
Targeted biologic therapy for immune-related disorders
Convenient pre-filled injection formulation for prescribed treatment plans

🔹 Dosage and Administration
Adalipca 40 mg Injection should be used only as prescribed by a specialist doctor
Administered by subcutaneous injection under medical guidance
Dose frequency depends on the condition being treated and the patient’s response
Do not stop treatment without consulting your doctor, even if symptoms improve
Regular monitoring may be required during therapy

🔹 Possible Side Effects
Common side effects may include:
Injection site pain, redness, or swelling
Headache
Nausea
Rash
Upper respiratory tract infections
Sinus inflammation
Increased risk of infections due to immune system suppression

🔹 Precautions
Use only under the supervision of a qualified healthcare professional
Inform your doctor if you have a history of tuberculosis, serious infections, hepatitis B, or immune system disorders
Screening for infections may be required before starting treatment
Avoid live vaccines during treatment unless advised by a doctor
Inform your healthcare provider about all medicines being taken
Consult your doctor before use during pregnancy or breastfeeding

Additional Information

  • Category: category change
  • Manufacturer: IPCA LABORTARIES LTD
  • Packaging: Vial
  • Composition: ADALIMUMAB INJECTION
  • Storage: Store in a cool, dry place away from direct sunlight
  • Shelf Life: As per manufacturer's guidelines
  • Prescription Status: Over-the-Counter (OTC)

How to Use

Important: Always follow your healthcare provider's instructions when using this medication.

  • Take this medicine as directed by your physician
  • Do not exceed the recommended dosage
  • Complete the full course of treatment even if symptoms improve
  • Store the medication properly as per storage instructions
  • Keep out of reach of children
  • Check expiry date before use

Note: This is general guidance. For specific instructions, please consult your healthcare provider or refer to the package insert.